BSE Live
Jan 02, 16:01Prev. Close
523.50
Open Price
524.60
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 02, 15:59Prev. Close
523.50
Open Price
525.50
Bid Price (Qty.)
518.30 (591)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Cohance Lifesciences (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 10.52 | 11.80 | 16.16 | 17.83 | 14.23 | |
| Diluted EPS (Rs.) | 10.45 | 11.80 | 16.16 | 17.83 | 14.23 | |
| Cash EPS (Rs.) | 13.44 | 13.94 | 18.03 | 17.75 | 13.37 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 66.64 | 80.56 | 68.16 | 59.99 | 46.39 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 66.64 | 80.56 | 68.16 | 59.99 | 46.39 | |
| Revenue from Operations/Share (Rs.) | 47.04 | 41.30 | 52.65 | 51.86 | 39.66 | |
| PBDIT/Share (Rs.) | 17.04 | 18.37 | 24.08 | 26.39 | 17.86 | |
| PBIT/Share (Rs.) | 13.99 | 16.23 | 22.20 | 24.85 | 16.62 | |
| PBT/Share (Rs.) | 13.51 | 15.94 | 21.99 | 24.61 | 16.26 | |
| Net Profit/Share (Rs.) | 10.40 | 11.80 | 16.16 | 16.21 | 12.12 | |
| NP After MI And SOA / Share (Rs.) | 10.52 | 11.80 | 16.16 | 17.83 | 14.23 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 36.21 | 44.48 | 45.72 | 50.88 | 45.03 | |
| PBIT Margin (%) | 29.74 | 39.29 | 42.16 | 47.92 | 41.90 | |
| PBT Margin (%) | 28.71 | 38.58 | 41.76 | 47.45 | 40.99 | |
| Net Profit Margin (%) | 22.10 | 28.56 | 30.68 | 31.25 | 30.56 | |
| NP After MI And SOA Margin (%) | 22.36 | 28.56 | 30.68 | 34.37 | 35.88 | |
| Return on Networth/Equity (%) | 15.78 | 14.64 | 23.70 | 29.71 | 30.68 | |
| Return on Capital Employed (%) | 13.36 | 19.24 | 31.27 | 39.07 | 33.71 | |
| Return on Assets (%) | 8.83 | 13.32 | 20.92 | 24.80 | 24.57 | |
| Total Debt/Equity (X) | 0.05 | 0.02 | 0.04 | 0.06 | 0.12 | |
| Asset Turnover Ratio (%) | 0.45 | 0.50 | 0.71 | 0.81 | 0.80 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 2.43 | 11.82 | 6.37 | 5.36 | 2.57 | |
| Quick Ratio (X) | 1.98 | 9.65 | 4.40 | 4.02 | 1.66 | |
| Inventory Turnover Ratio (X) | 6.02 | 3.87 | 1.44 | 1.90 | 1.65 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 49.51 | 22.43 | 7.02 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 44.36 | 20.65 | 6.46 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 50.49 | 77.57 | 92.98 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 55.64 | 79.35 | 93.54 | |
| Coverage Ratios | ||||||
| Interest Coverage Ratios (%) | 35.12 | 62.77 | 112.74 | 107.82 | 49.73 | |
| Interest Coverage Ratios (Post Tax) (%) | 35.12 | 62.77 | 112.74 | 107.82 | 49.73 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 29,662.03 | 17,211.94 | 12,039.36 | 15,779.11 | 12,742.73 | |
| EV/Net Operating Revenue (X) | 24.77 | 16.37 | 8.98 | 11.95 | 12.62 | |
| EV/EBITDA (X) | 68.38 | 36.80 | 19.64 | 23.49 | 28.02 | |
| MarketCap/Net Operating Revenue (X) | 24.66 | 16.38 | 8.98 | 11.92 | 12.49 | |
| Retention Ratios (%) | 0.00 | 0.00 | 50.48 | 77.56 | 92.97 | |
| Price/BV (X) | 17.40 | 8.40 | 6.93 | 10.30 | 10.68 | |
| Price/Net Operating Revenue | 24.66 | 16.38 | 8.98 | 11.92 | 12.49 | |
| Earnings Yield | 0.01 | 0.02 | 0.03 | 0.03 | 0.03 |
04.12.2025
Cohance Life Consolidated September 2025 Net Sales at Rs 555.57 crore, up 115.57% Y-o-Y
27.11.2025
Cohance Life Standalone September 2025 Net Sales at Rs 497.79 crore, up 110.87% Y-o-Y
12.06.2025
Cohance Life Standalone March 2025 Net Sales at Rs 330.17 crore, up 35.58% Y-o-Y
04.03.2025
Suven Pharma Consolidated December 2024 Net Sales at Rs 307.15 crore, up 39.73% Y-o-Y